tetradecanoylphorbol acetate and apicularen a

tetradecanoylphorbol acetate has been researched along with apicularen a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hwang, BD; Kim, JS; Kweon, GR; Lim, K; Park, JH; Park, JI; Seo, KS; Song, KS; Yoon, WH; Yun, EJ	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and apicularen a

Article	Year
PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells. BMC cancer, 2014, Jan-22, Volume: 14 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Cell Cycle Checkpoints; Cell Survival; Drug Synergism; Female; HeLa Cells; Humans; Microtubules; Protein Kinase C-alpha; Protein Kinase Inhibitors; RNA Interference; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Tubulin; Tubulin Modulators; Uterine Cervical Neoplasms	2014

Article

Year

PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells.

BMC cancer, 2014, Jan-22, Volume: 14

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Cell Cycle Checkpoints; Cell Survival; Drug Synergism; Female; HeLa Cells; Humans; Microtubules; Protein Kinase C-alpha; Protein Kinase Inhibitors; RNA Interference; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Tubulin; Tubulin Modulators; Uterine Cervical Neoplasms

2014